You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Merck
Mallinckrodt
Johnson and Johnson
Baxter

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Patent: 5,120,499

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,120,499
Title: Method and system for asepticizing contact lenses and storing device
Abstract:Light-transmitting contact lenses of Polymethylacrylate, Gas Permeable of Hydrogel materials may be immersed in an aqueous liquid medium contained in a storing and processing device, all of which are substantially transparent to the ultraviolet radiation spectrum. The lenses, liquid medium and storing device are all irradiated with ultraviolet radiation in a preselected frequency range, while simultaneously being subjected to ultrasonic frequency vibrations to thereby cause asepticization of lenses, liquid medium and storing device. The ultraviolet irradiation and ultrasonic vibrations are insufficient to cause detrimental molecular modification to the lenses or storing device, but does cause the formation of oxidation free radicals in the liquid medium. The unique combination of ultraviolet irradiation and ultrasonic vibration in the presence of the liquid medium containing oxidation free radicals cause rapid destruction of all microorganisms associated with the lenses, liquid medium and storing device.
Inventor(s): Baron; Neville A. (Secaucus, NJ)
Assignee: U. V. Black Box Corporation (Line Lexington, PA)
Application Number:07/463,451
Patent Claims:see list of patent claims

Details for Patent 5,120,499

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial U. V. Black Box Corporation (Line Lexington, PA) 2039-09-23 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial U. V. Black Box Corporation (Line Lexington, PA) 2039-09-23 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Medtronic
Merck
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.